Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

482 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Favorable Trend of Implantable Cardioverter-Defibrillator Service Life in a Large Single-Nation Population: Insights From 10-Year Analysis of the Italian Implantable Cardioverter-Defibrillator Registry.
Poli S, Boriani G, Zecchin M, Facchin D, Gasparini M, Landolina M, Ricci RP, Lanera C, Gregori D, Proclemer A. Poli S, et al. Among authors: gasparini m. J Am Heart Assoc. 2019 Aug 6;8(15):e012759. doi: 10.1161/JAHA.119.012759. Epub 2019 Jul 25. J Am Heart Assoc. 2019. PMID: 31340695 Free PMC article.
Avoid delivering therapies for nonsustained fast ventricular tachyarrhythmia in patients with implantable cardioverter/defibrillator: the ADVANCE III Trial.
Schwab JO, Gasparini M, Lunati M, Proclemer A, Kaup B, Santi E, Ligorio G, Klersy C, DE Sousa J, Okreglicki A, Arenal A, Wijffels M, Lemke B. Schwab JO, et al. Among authors: gasparini m. J Cardiovasc Electrophysiol. 2009 Jun;20(6):663-6. doi: 10.1111/j.1540-8167.2008.01415.x. Epub 2009 Jan 9. J Cardiovasc Electrophysiol. 2009. PMID: 19175450 Clinical Trial.
Determinants of all-cause mortality in different age groups in patients with severe systolic left ventricular dysfunction receiving an implantable cardioverter defibrillator (from the Italian ClinicalService Multicenter Observational Project).
Fumagalli S, Gasparini M, Landolina M, Lunati M, Boriani G, Proclemer A, Santini M, Mangoni L, Padeletti M, Marchionni N, Padeletti L; Italian ClinicalService Project Centers. Fumagalli S, et al. Among authors: gasparini m. Am J Cardiol. 2014 May 15;113(10):1691-6. doi: 10.1016/j.amjcard.2014.02.025. Epub 2014 Mar 2. Am J Cardiol. 2014. PMID: 24792738
Efficacy of long detection interval implantable cardioverter-defibrillator settings in secondary prevention population: data from the Avoid Delivering Therapies for Nonsustained Arrhythmias in ICD Patients III (ADVANCE III) trial.
Kloppe A, Proclemer A, Arenal A, Lunati M, Martìnez Ferrer JB, Hersi A, Gulaj M, Wijffels MC, Santi E, Manotta L, Mangoni L, Gasparini M. Kloppe A, et al. Among authors: gasparini m. Circulation. 2014 Jul 22;130(4):308-14. doi: 10.1161/CIRCULATIONAHA.114.009468. Epub 2014 May 16. Circulation. 2014. PMID: 24838360 Clinical Trial.
Ventricular antitachycardia pacing therapy in patients with heart failure implanted with a cardiac resynchronization therapy defibrillator device: Efficacy, safety, and impact on mortality.
Landolina M, Lunati M, Boriani G, Pietro Ricci R, Proclemer A, Facchin D, Rordorf R, Morani G, Maines M, Gasparini G, Molon G, Turrini P, Gasparini M; ClinicalService cardiological centers. Landolina M, et al. Among authors: gasparini m, gasparini g. Heart Rhythm. 2016 Feb;13(2):472-80. doi: 10.1016/j.hrthm.2015.10.022. Epub 2015 Oct 23. Heart Rhythm. 2016. PMID: 26477710 Clinical Trial.
Different impact of long-detection interval and anti-tachycardia pacing in reducing unnecessary shocks: data from the ADVANCE III trial.
Arenal A, Proclemer A, Kloppe A, Lunati M, Martìnez Ferrer JB, Hersi A, Gulaj M, Wijffels MC, Santi E, Manotta L, Mangoni L, Gasparini M. Arenal A, et al. Among authors: gasparini m. Europace. 2016 Nov;18(11):1719-1725. doi: 10.1093/europace/euw032. Epub 2016 Aug 2. Europace. 2016. PMID: 27485577 Free PMC article. Clinical Trial.
Long Detection Programming in Single-Chamber Defibrillators Reduces Unnecessary Therapies and Mortality: The ADVANCE III Trial.
Gasparini M, Lunati MG, Proclemer A, Arenal A, Kloppe A, Martínez Ferrer JB, Hersi AS, Gulaj M, Wijffels MCE, Santi E, Manotta L, Varma N. Gasparini M, et al. JACC Clin Electrophysiol. 2017 Nov;3(11):1275-1282. doi: 10.1016/j.jacep.2017.05.001. Epub 2017 May 31. JACC Clin Electrophysiol. 2017. PMID: 29759624 Free article. Clinical Trial.
482 results